NCT03085381View on ClinicalTrials.gov

A Phase I Study of Quadrivalent HPV Recombinant Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

August 31, 2018

Conditions
HPV Infections
Interventions
BIOLOGICAL

HPV vaccine

BIOLOGICAL

Placebo

Trial Locations (1)

Unknown

Liu Zhou Centre for Disease Control and Prevention, Liuzhou

All Listed Sponsors
lead

Shanghai Bovax Biotechnology Co., Ltd.

INDUSTRY

NCT03085381 - A Phase I Study of Quadrivalent HPV Recombinant Vaccine | Biotech Hunter | Biotech Hunter